JP2010522699A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010522699A5 JP2010522699A5 JP2010500039A JP2010500039A JP2010522699A5 JP 2010522699 A5 JP2010522699 A5 JP 2010522699A5 JP 2010500039 A JP2010500039 A JP 2010500039A JP 2010500039 A JP2010500039 A JP 2010500039A JP 2010522699 A5 JP2010522699 A5 JP 2010522699A5
- Authority
- JP
- Japan
- Prior art keywords
- scoliosis
- opn
- subject
- expression
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004264 Osteopontin Human genes 0.000 claims 35
- 108010081689 Osteopontin Proteins 0.000 claims 35
- 238000000034 method Methods 0.000 claims 34
- 206010039722 scoliosis Diseases 0.000 claims 28
- 239000000523 sample Substances 0.000 claims 13
- 239000003795 chemical substances by application Substances 0.000 claims 12
- 230000002265 prevention Effects 0.000 claims 9
- 238000002965 ELISA Methods 0.000 claims 4
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims 4
- 102100032912 CD44 antigen Human genes 0.000 claims 3
- 208000022567 adolescent idiopathic scoliosis Diseases 0.000 claims 3
- 239000013060 biological fluid Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000005259 measurement Methods 0.000 claims 3
- 229940122231 Osteopontin inhibitor Drugs 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 239000003446 ligand Substances 0.000 claims 2
- 238000003127 radioimmunoassay Methods 0.000 claims 2
- 230000004936 stimulating effect Effects 0.000 claims 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000013068 control sample Substances 0.000 claims 1
- 230000037213 diet Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000001964 muscle biopsy Methods 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 229910052711 selenium Inorganic materials 0.000 claims 1
- 239000011669 selenium Substances 0.000 claims 1
- 210000001138 tear Anatomy 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90940807P | 2007-03-30 | 2007-03-30 | |
| US60/909,408 | 2007-03-30 | ||
| US2557108P | 2008-02-01 | 2008-02-01 | |
| US61/025,571 | 2008-02-01 | ||
| PCT/CA2008/000595 WO2008119170A1 (en) | 2007-03-30 | 2008-03-31 | Method of determining risk of scoliosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010522699A JP2010522699A (ja) | 2010-07-08 |
| JP2010522699A5 true JP2010522699A5 (enExample) | 2011-04-28 |
| JP5426530B2 JP5426530B2 (ja) | 2014-02-26 |
Family
ID=39807753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010500039A Expired - Fee Related JP5426530B2 (ja) | 2007-03-30 | 2008-03-31 | 脊柱側弯症の危険性の決定方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20100075333A1 (enExample) |
| EP (1) | EP2132568B1 (enExample) |
| JP (1) | JP5426530B2 (enExample) |
| KR (1) | KR101436578B1 (enExample) |
| CN (1) | CN101680887B (enExample) |
| AU (1) | AU2008234374B2 (enExample) |
| CA (1) | CA2682114C (enExample) |
| IL (1) | IL201186A (enExample) |
| MX (1) | MX2009010400A (enExample) |
| WO (1) | WO2008119170A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9029094B2 (en) * | 2010-10-04 | 2015-05-12 | Chu Sainte-Justine | Biomechanical-based methods of diagnosing scoliosis |
| DE102012102338A1 (de) | 2012-03-20 | 2013-09-26 | Hauni Maschinenbau Ag | Messanordnung zum Messen von in Strangmaschinen der Tabak verarbeitenden Industrie hergestellten und geförderten Strängen |
| US20150038511A1 (en) | 2012-08-09 | 2015-02-05 | Celgene Corporation | Treatment of immune-related and inflammatory diseases |
| AU2013299625B2 (en) * | 2012-08-09 | 2018-02-01 | Celgene Corporation | Treatment of immune-related and inflammatory diseases |
| US20160368992A1 (en) * | 2013-06-17 | 2016-12-22 | Chu Sainte-Justine | A method of increasing gipcr signalization in the cells of a scoliotic subject |
| WO2014201557A1 (en) | 2013-06-17 | 2014-12-24 | Chu Ste-Justine | Gi protein phosphorylation as marker for scoliosis and scoliosis progression, methods of increasing gipcr signaling in scoliotic subjects |
| WO2014201560A1 (en) | 2013-06-17 | 2014-12-24 | Chu Ste-Justine | New markers for severe progression of idiopathic scoliosis and uses thereof to stratify scoliotic patients and predict the risk of developing scoliosis |
| WO2015032004A1 (en) | 2013-09-09 | 2015-03-12 | Chu Sainte-Justine | Method of treating and prognosing scoliotic patient subgroups |
| ES2969532T3 (es) | 2014-05-19 | 2024-05-21 | Celgene Corp | 3-(4-((4-(Morfolinometil-bencil)oxi)-1-oxoisoindolin-2-il)piperidin-2,6-diona para el tratamiento de lupus eritematoso sistémico |
| CN106310610A (zh) * | 2016-10-21 | 2017-01-11 | 上海交通大学医学院附属新华医院 | 一种脊柱侧凸特定运动疗法 |
| CN106841593B (zh) * | 2017-03-24 | 2018-08-17 | 北京致成生物医学科技有限公司 | Lacc1和fhl2基因在制备脊柱侧弯检测产品中的应用 |
| CN111638329B (zh) * | 2020-06-09 | 2021-06-01 | 南方医科大学 | 一种用于检测布鲁氏菌病elispot检测试剂盒及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5618920A (en) * | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
| SE9101642D0 (sv) * | 1991-05-30 | 1991-05-30 | Kabi Pharmacia Ab | Phospholipids |
| EP0767378A1 (de) * | 1993-06-22 | 1997-04-09 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Verfahren zur Diagnose und Analyse von Magenkarzinomen |
| HUT76846A (en) | 1994-08-30 | 1997-12-29 | Hyal Pharma Corp | Hyaluronic acid and derivatives for modulation of cellular activity |
| US5858709A (en) * | 1996-10-15 | 1999-01-12 | Smithkline Beecham P.L.C. | Fibronectin binding protein B compounds |
| US6025155A (en) * | 1996-04-10 | 2000-02-15 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| US20020160970A1 (en) * | 1996-04-10 | 2002-10-31 | Gyula Hadlaczky | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| WO1998008379A1 (en) | 1996-08-27 | 1998-03-05 | Dana-Farber Cancer Institute | Methods for identifying modulators of cellular interactions mediated by osteopontin |
| US6150162A (en) * | 1998-12-17 | 2000-11-21 | Isis Pharmaceuticals Inc. | Antisense modulation of CD44 expression |
| AU3149200A (en) | 1999-01-18 | 2000-08-01 | Osteometer Biotech As | Genetic predisposition |
| JP2002543775A (ja) * | 1999-04-15 | 2002-12-24 | チルドレンズ メディカル センター コーポレーション | オステオポンチン由来の走化性および阻害性の薬剤およびその使用 |
| US7504232B2 (en) | 2000-03-23 | 2009-03-17 | Smithkline Beecham Corporation | Method of screening for inhibitors of osteopontin |
| CA2461529A1 (en) * | 2001-09-25 | 2003-04-03 | Immuno-Biological Laboratories Co., Ltd. | Recombinant anti-osteopontin antibody and use thereof |
| CA2373854A1 (en) * | 2002-02-28 | 2003-08-28 | Alain Moreau | Methods of diagnosing and counteracting adolescent idiopathic scoliosis |
| EP1532268A4 (en) * | 2002-03-21 | 2006-07-05 | Yissum Res Dev Co | PERIPHERAL BLOOD CELL MARKERS SUITABLE FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS AND THESE USEFUL METHODS AND KITS |
| US20040110933A1 (en) * | 2002-09-13 | 2004-06-10 | Dyax Corporation | CD44-binding ligands |
| US20050282163A1 (en) * | 2003-02-03 | 2005-12-22 | Medstar Research Institute Washington Hospital Center | Polymorphisms in elastin, fibrillin and related genes as predisposing to restenosis and to a therosclerosis |
| US20090104620A1 (en) * | 2007-07-03 | 2009-04-23 | Axial Biotech, Inc. | Simplified Method of Determining Predisposition to Scoliosis |
-
2008
- 2008-03-31 WO PCT/CA2008/000595 patent/WO2008119170A1/en not_active Ceased
- 2008-03-31 CA CA2682114A patent/CA2682114C/en not_active Expired - Fee Related
- 2008-03-31 AU AU2008234374A patent/AU2008234374B2/en not_active Ceased
- 2008-03-31 JP JP2010500039A patent/JP5426530B2/ja not_active Expired - Fee Related
- 2008-03-31 KR KR1020097022732A patent/KR101436578B1/ko not_active Expired - Fee Related
- 2008-03-31 MX MX2009010400A patent/MX2009010400A/es active IP Right Grant
- 2008-03-31 CN CN200880017111.6A patent/CN101680887B/zh not_active Expired - Fee Related
- 2008-03-31 US US12/594,181 patent/US20100075333A1/en not_active Abandoned
- 2008-03-31 EP EP08733693.9A patent/EP2132568B1/en not_active Not-in-force
-
2009
- 2009-09-24 IL IL201186A patent/IL201186A/en active IP Right Grant
-
2013
- 2013-02-22 US US13/775,069 patent/US20130266966A1/en not_active Abandoned
-
2015
- 2015-07-23 US US14/807,450 patent/US10073101B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010522699A5 (enExample) | ||
| Balzar et al. | Increased TGF-β2 in severe asthma with eosinophilia | |
| ES2897419T3 (es) | Procedimientos de predicción del riesgo de un resultado clínico adverso | |
| US10132809B2 (en) | Differential expression of protein markers for the diagnosis and treatment of eosinophilic esophagitis | |
| ES2403310T3 (es) | Antibiótico para su utilización en una infección local | |
| ES2717900T3 (es) | Método para la detección temprana de enfermedad y lesión renal | |
| Feld et al. | Endpoints of therapy in chronic hepatitis B | |
| Qian et al. | Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis | |
| RU2014118584A (ru) | Композиции и способы лечения сердечной недостаточности | |
| JP2010516678A5 (enExample) | ||
| JP2013534313A (ja) | 腸の炎症状態の生物学的マーカーとしてのｈｍｇｂ１の使用、糞便サンプル中のｈｍｇｂ１を検出するための非侵襲法およびそのキット | |
| JP2012509477A5 (enExample) | ||
| Stanescu et al. | Salivary biomarkers of inflammation in systemic lupus erythematosus | |
| Banaszak et al. | Endothelin-1 (ET-1), N-terminal fragment of pro-atrial natriuretic peptide (NTpro-ANP), and tumour necrosis factor alpha (TNF-α) in children with primary hypertension and hypertension of renal origin | |
| RU2008116567A (ru) | Биомаркеры | |
| Yuan et al. | High expression of interleukin-33/ST2 predicts the progression and poor prognosis in chronic hepatitis B patients with hepatic flare | |
| JP2012526543A5 (enExample) | ||
| Li et al. | Thyrotropin receptor antibody: A novel risk indicator for pregnancy loss | |
| JP2021170021A (ja) | 糖尿病性腎症の早期病態の特異的な診断を可能とする検査方法 | |
| Hanibuchi et al. | Clinical significance of fractional exhaled nitric oxide and periostin as potential markers to assess therapeutic efficacy in patients with cough variant asthma | |
| Swedin et al. | Prostaglandin modulation of airway inflammation and hyperresponsiveness in mice sensitized without adjuvant | |
| Kikuchi et al. | Urinary and circulating levels of the anti-angiogenic isoform of vascular endothelial growth factor-A in patients with chronic kidney disease | |
| EP2504699A1 (en) | Methods of detecting or monitoring activity of an inflammatory or neurodegenerative condition | |
| Armanini et al. | Pitfalls in urinary sodium excretion | |
| Hussein et al. | Role of cartilage oligomeric matrix protein (COMP) as a prognostic biomarker in follow-up of early rheumatoid arthritis patients: correlation to musculoskeletal ultrasonographic findings |